Form 4 Tracker
TriSalus Life Sciences, Inc.
TLSI

28 insider filings · Latest: Jun 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 23, 2026Feb 23 9:08 PMDavid PatienceChief Financial Officer
Purchase
3,657$4.10$15.0K268,657(D)

View →

Feb 23, 2026Feb 23 9:08 PMGary B. GordonDirector
Purchase
9,756$4.10$40.0K9,756(D)

View →

Feb 23, 2026Feb 23 9:08 PMWilliam ValleDirector
Purchase
30,487$4.10$125.0K30,487(D)

View →

Feb 23, 2026Feb 23 9:08 PMMary T SzelaDirector, CEO and President
Purchase
30,487$4.10$125.0K773,289(D)

View →

Feb 23, 2026Feb 23 9:08 PMStansky Michael PDirector
Purchase
361,098$4.10$1.5M199,698(I)

View →

Dec 10, 2024Dec 10 9:06 PMArjun Desai
Proposed Sale
30,000$4.50$135.0K

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 29, 2026Jun 29 8:33 PMRichard Henry MarshallChief Medical Officer
Grant/Award
120,000$4.74253,000(D)

View →

May 14, 2026May 15 8:39 PMHICKS KERRY RDirector
Grant/Award
56,403$2.52145,625(D)

View →

May 14, 2026May 15 8:39 PMWahlstrom MatsDirector
Grant/Award
75,204$2.52276,149(D)

View →

May 14, 2026May 15 8:39 PMGary B. GordonDirector
Grant/Award
56,403$2.52112,653(D)

View →

May 14, 2026May 15 8:39 PMMATLIN DAVID JDirector
Grant/Award
56,403$2.52121,403(D)

View →

May 14, 2026May 15 8:39 PMWilliam ValleDirector
Grant/Award
56,403$2.52112,653(D)

View →

May 14, 2026May 15 8:39 PMStansky Michael PDirector
Grant/Award
47,003$2.52139,540(D)

View →

Jul 31, 2025Apr 20 8:36 PMFrankenius Equity AB10% Owner
Conversion
230,0000(D)

View →

Jul 31, 2025Apr 1 8:09 PMMATLIN DAVID JDirector
Conversion
100,0000(D)

View →

Feb 4, 2026Feb 11 11:51 PMStansky Michael PDirector
Grant/Award
92,537$4.9192,537(D)

View →